Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect
ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES

1,3-Diarylindan-2-carboxylic Acids, Potent and Selective Non-Peptide Endothelin Receptor Antagonists

Cite this: J. Med. Chem. 1994, 37, 11, 1553–1557
Publication Date (Print):May 1, 1994
https://doi.org/10.1021/jm00037a003
    ACS Legacy Archive

    Article Views

    403

    Altmetric

    -

    Citations

    LEARN ABOUT THESE METRICS
    Other access options

    Note: In lieu of an abstract, this is the article's first page.

    Free first page

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. You can change your affiliated institution below.

    Cited By

    This article is cited by 119 publications.

    1. Wanyao Hu, Cong Zhang, Jie Huang, Yingying Guo, Zhenqian Fu, Wei Huang. Access to Highly Functionalized Indanes from Arynes and α,γ-Diketo Esters. Organic Letters 2019, 21 (4) , 941-945. https://doi.org/10.1021/acs.orglett.8b03919
    2. Liping Yu, Shuai-Shuai Li, Weina Li, Shitao Yu, Qing Liu, Jian Xiao. Fluorinated Alcohol-Promoted Reaction of Chlorohydrocarbons with Diverse Nucleophiles for the Synthesis of Triarylmethanes and Tetraarylmethanes. The Journal of Organic Chemistry 2018, 83 (24) , 15277-15283. https://doi.org/10.1021/acs.joc.8b02549
    3. Mathai George, Valarkottu S. Sebastian, Putluri Nagi Reddy, Ragampeta Srinivas, Daryl Giblin, Michael L. Gross. Gas-phase nazarov cyclization of protonated 2-methoxy and 2-hydroxychalcone: An example of intramolecular proton-transport catalysis. Journal of the American Society for Mass Spectrometry 2009, 20 (5) , 805-818. https://doi.org/10.1016/j.jasms.2008.12.017
    4. Cristina Navarro and, Aurelio G. Csákÿ. Stereoselective RhI-Catalyzed Tandem Conjugate Addition of Boronic Acids−Michael Cyclization. Organic Letters 2008, 10 (2) , 217-219. https://doi.org/10.1021/ol702571c
    5. Jade S. Blakeney,, Robert C. Reid,, Giang T. Le, and, David P. Fairlie. Nonpeptidic Ligands for Peptide-Activated G Protein-Coupled Receptors. Chemical Reviews 2007, 107 (7) , 2960-3041. https://doi.org/10.1021/cr050984g
    6. William M. Clark,, Ann M. Tickner-Eldridge,, G. Kris Huang,, Lendon N. Pridgen,, Mark A. Olsen,, Robert J. Mills,, Ivan Lantos, and, Neil H. Baine. A Catalytic Enantioselective Synthesis of the Endothelin Receptor Antagonists SB-209670 and SB-217242. A Base-Catalyzed Stereospecific Formal 1,3-Hydrogen Transfer of a Chiral 3-Arylindenol. Journal of the American Chemical Society 1998, 120 (18) , 4550-4551. https://doi.org/10.1021/ja973882j
    7. William C. Patt,, Jeremy J. Edmunds,, Joseph T. Repine,, Kent A. Berryman,, Billy R. Reisdorph,, Chet Lee,, Mark S. Plummer,, Aurash Shahripour,, Stephen J. Haleen,, Joan A. Keiser,, Mike A. Flynn,, Kathleen M. Welch,, Elwood E. Reynolds,, Ron Rubin,, Brian Tobias,, Hussein Hallak, and, Annette M. Doherty. Structure−Activity Relationships in a Series of Orally Active γ-Hydroxy Butenolide Endothelin Antagonists. Journal of Medicinal Chemistry 1997, 40 (7) , 1063-1074. https://doi.org/10.1021/jm9606507
    8. Hartmut Riechers,, Hans-Peter Albrecht,, Willi Amberg,, Ernst Baumann,, Harald Bernard,, Hans-Joachim Böhm,, Dagmar Klinge,, Andreas Kling,, Stefan Müller,, Manfred Raschack,, Liliane Unger,, Nigel Walker, and, Wolfgang Wernet. Discovery and Optimization of a Novel Class of Orally Active Nonpeptidic Endothelin-A Receptor Antagonists. Journal of Medicinal Chemistry 1996, 39 (11) , 2123-2128. https://doi.org/10.1021/jm960274q
    9. Teresa Mancilla Percino, Maricarmen Hernández Rodríguez, Elvia Mera Jiménez. Synthesis of New Isoindolines Derived from L‐Α‐Amino Acids and their Selectivity on Cancer Cell Lines. ChemistrySelect 2024, 9 (4) https://doi.org/10.1002/slct.202304299
    10. Nobuyoshi Morita, Hitomi Chiaki, Kanae Ikeda, Kosaku Tanaka, Yoshimitsu Hashimoto, Osamu Tamura. Gold-Catalyzed Formal (3+2) Cycloaddition in an Ionic Liquid: Environmentally Friendly and Stereoselective Synthesis of Polysubstituted Indanes from Benzylic Alcohols and 1-Phenylpropenes. Synlett 2023, 34 (09) , 1068-1074. https://doi.org/10.1055/a-2002-4122
    11. Yu Zhou, Dandan Hu, Yuting Zhang, Qiyou Cen, Zhi‐Bing Dong, Jun‐Qi Zhang, Hongjun Ren. Transition‐Metal‐Free Synthesis of Polyfluoro‐Polyarylmethanes via Direct Cross‐Coupling of Polyfluoroarenes and Benzyl Chlorides. Chemistry – A European Journal 2023, 29 (19) https://doi.org/10.1002/chem.202203427
    12. Nobuyoshi Morita, Osamu Tamura. Strategic Use of Difference of Valence of Gold Catalysts: Development of Cyclization Reactions Oriented toward Synthetic Diversity Using Propargylic Alcohols. Journal of Synthetic Organic Chemistry, Japan 2021, 79 (7) , 652-663. https://doi.org/10.5059/yukigoseikyokaishi.79.652
    13. Anton V. Yadykov, Liana V. Yaminova, Mikhail M. Krayushkin, Valerii Z. Shirinian. Cyclization of Polarized Divinyl Ketones under Aqueous and Ambient Conditions. Advanced Synthesis & Catalysis 2021, 363 (1) , 251-258. https://doi.org/10.1002/adsc.202000956
    14. Bing-Kai Tao, Hua Yang, Yuan-Zhao Hua, Min-Can Wang. Dinuclear zinc synergistic catalytic asymmetric phospha-Michael/Michael cascade reaction: synthesis of 1,2,3-trisubstituted indanes bearing phosphoryl groups. Organic & Biomolecular Chemistry 2019, 17 (17) , 4301-4310. https://doi.org/10.1039/C9OB00544G
    15. M.H. Bolli, C. Boss, J. Gatfield, M. Iglarz, A. Treiber. The Discovery of Macitentan—A Standard Medicinal Chemistry Program?. 2017, 252-283. https://doi.org/10.1016/B978-0-12-409547-2.12455-2
    16. Nobuyoshi Morita, Masazumi Miyamoto, Akiyoshi Yoda, Mari Yamamoto, Shintaro Ban, Yoshimitsu Hashimoto, Osamu Tamura. Gold-catalyzed dehydrative Friedel–Crafts reaction and Nazarov cyclization sequence: an efficient synthesis of 1,3-diarylindenes from propargylic alcohols. Tetrahedron Letters 2016, 57 (40) , 4460-4463. https://doi.org/10.1016/j.tetlet.2016.08.045
    17. Christoph Boss, Martin H. Bolli, John Gatfield. From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspective. Bioorganic & Medicinal Chemistry Letters 2016, 26 (15) , 3381-3394. https://doi.org/10.1016/j.bmcl.2016.06.014
    18. Yali Li, Lingjuan Zhang, Zongyao Zhang, Jianbin Xu, Yixiao Pan, Conghui Xu, Lingxian Liu, Zengguang Li, Zhiyong Yu, Huanrong Li, Lijin Xu. Regio‐ and Stereoselective Synthesis of 1,2,3‐Trisubstituted Indanes from Diarylmethanols and Allylamides through Iron(III) Chloride Hexahydrate. Advanced Synthesis & Catalysis 2016, 358 (13) , 2148-2155. https://doi.org/10.1002/adsc.201600165
    19. Maris Vilums, Jules Heuberger, Laura H. Heitman, Adriaan P. IJzerman. Indanes—Properties, Preparation, and Presence in Ligands for G Protein Coupled Receptors. Medicinal Research Reviews 2015, 35 (6) , 1097-1126. https://doi.org/10.1002/med.21352
    20. Masaki Shimizu. Lithium Compounds in Cross‐Coupling Reactions. 2014, 463-490. https://doi.org/10.1002/9783527667512.ch16
    21. Xiao-Hui Li, Ping Fang, Di Chen, Xue-Long Hou. Kinetic resolution of 4-substituted-3,4-dihydrocoumarins via Pd-catalyzed asymmetric allylic alkylation reaction: enantioselective synthesis of trans-3,4-disubstituted-3,4-dihydrocoumarins. Org. Chem. Front. 2014, 1 (8) , 969-973. https://doi.org/10.1039/C4QO00178H
    22. Stephen P.H. Alexander, Helen E. Benson, Elena Faccenda, Adam J. Pawson, Joanna L. Sharman, Michael Spedding, John A. Peters, Anthony J. Harmar, . The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors. British Journal of Pharmacology 2013, 170 (8) , 1459-1581. https://doi.org/10.1111/bph.12445
    23. Gregory Rosocha, Robert A. Batey. Synthesis of 2-bromo-1-aryl-1H-indenes via a Ag(I) promoted domino 2π-electrocyclic ring-opening/4π-electrocyclization reaction of 1,2-diaryl substituted gem-dibromocyclopropanes. Tetrahedron 2013, 69 (41) , 8758-8768. https://doi.org/10.1016/j.tet.2013.07.086
    24. Hongling Yuan, Junhao Hu, Yuefa Gong. Asymmetric synthesis of 1,2,3-trisubstituted indanes via an enantioselective copper(II)-catalyzed asymmetric nitroaldol reaction followed by an intramolecular Michael cyclization. Tetrahedron: Asymmetry 2013, 24 (12) , 699-705. https://doi.org/10.1016/j.tetasy.2013.05.005
    25. Pablo Etayo, Anton Vidal-Ferran. Rhodium-catalysed asymmetric hydrogenation as a valuable synthetic tool for the preparation of chiral drugs. Chem. Soc. Rev. 2013, 42 (2) , 728-754. https://doi.org/10.1039/C2CS35410A
    26. Dana Ameen, Timothy J. Snape. Chiral 1,1-diaryl compounds as important pharmacophores. MedChemComm 2013, 4 (6) , 893. https://doi.org/10.1039/c3md00088e
    27. Janet J. Maguire, Rhoda E. Kuc, Anthony P. Davenport. Defining the affinity and receptor sub-type selectivity of four classes of endothelin antagonists in clinically relevant human cardiovascular tissues. Life Sciences 2012, 91 (13-14) , 681-686. https://doi.org/10.1016/j.lfs.2012.05.008
    28. Janet J. Maguire, Anthony P. Davenport. Importance of Subtype Selectivity for Endothelin Receptor Antagonists in the Human Vasculature. 2012, 151-172. https://doi.org/10.1007/978-0-85729-920-8_10
    29. Beatriz Lantaño, Jose Manuel Aguirre, Esteban Ariel Ugliarolo, Rosario Torviso, Nicolás Pomilio, Graciela Yolanda Moltrasio. Scope of the formal [3+2] cycloaddition for the synthesis of five-membered ring of functionalized indanes. Tetrahedron 2012, 68 (3) , 913-921. https://doi.org/10.1016/j.tet.2011.10.089
    30. Hardik J. Patel, Nicole Olgun, István Lengyel, Sandra Reznik, Ralph A. Stephani. Synthesis and pharmacological activity of 1,3,6-trisubstituted-4-oxo-1,4-dihydroquinoline-2-carboxylic acids as selective ETA antagonists. Bioorganic & Medicinal Chemistry Letters 2010, 20 (22) , 6840-6844. https://doi.org/10.1016/j.bmcl.2010.08.074
    31. Hyohyun Kim, Jaesook Yun. Copper‐Catalyzed Asymmetric 1,4‐Hydroboration of Coumarins with Pinacolborane: Asymmetric Synthesis of Dihydrocoumarins. Advanced Synthesis & Catalysis 2010, 352 (11-12) , 1881-1885. https://doi.org/10.1002/adsc.201000310
    32. Faquan Liang, Christopher B. Glascock, Denise L. Schafer, Jennifer Sandoval, LouAnn Cable, Lawrence Melvin, J. Craig Hartman, Kelly R. Pitts. Darusentan is a potent inhibitor of endothelin signaling and function in both large and small arteriesThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.. Canadian Journal of Physiology and Pharmacology 2010, 88 (8) , 840-849. https://doi.org/10.1139/Y10-061
    33. Genette I. McGrew, Jesada Temaismithi, Patrick J. Carroll, Patrick J. Walsh. Synthesis of Polyarylated Methanes through Cross‐Coupling of Tricarbonylchromium‐Activated Benzyllithiums. Angewandte Chemie 2010, 122 (32) , 5673-5676. https://doi.org/10.1002/ange.201000957
    34. Genette I. McGrew, Jesada Temaismithi, Patrick J. Carroll, Patrick J. Walsh. Synthesis of Polyarylated Methanes through Cross‐Coupling of Tricarbonylchromium‐Activated Benzyllithiums. Angewandte Chemie International Edition 2010, 49 (32) , 5541-5544. https://doi.org/10.1002/anie.201000957
    35. Guillaume Berthon, Tamio Hayashi. Rhodium‐ and Palladium‐Catalyzed Asymmetric Conjugate Additions. 2010, 1-70. https://doi.org/10.1002/9783527630578.ch1
    36. Klaus Kopka, Stefan Wagner, Michael Schäfers, Andreas Faust, Otmar Schober, Günter Haufe. 18F‐Labeled PET‐Tracers for Cardiological Imaging. 2008, 85-139. https://doi.org/10.1016/B978-0-444-53086-8.00003-5
    37. Takashi Nishikata, Yasunori Yamamoto, Norio Miyaura. Palladium(II)‐Catalyzed 1,4‐Addition of Arylboronic Acids to β‐Arylenones for Enantioselective Synthesis of 4‐Aryl‐4 H ‐chromenes. Advanced Synthesis & Catalysis 2007, 349 (10) , 1759-1764. https://doi.org/10.1002/adsc.200600622
    38. Janet J. Maguire, Anthony Davenport. Endothelin Receptors. 2007, 1-3. https://doi.org/10.1016/B978-008055232-3.60159-X
    39. Takahiro Itoh, Toshiaki Mase, Takashi Nishikata, Tetsuji Iyama, Hiroto Tachikawa, Yuri Kobayashi, Yasunori Yamamoto, Norio Miyaura. 1,4-Addition of arylboronic acids to β-aryl-α,β-unsaturated ketones and esters catalyzed by a rhodium(I)–chiraphos complex for catalytic and enantioselective synthesis of selective endothelin A receptor antagonists. Tetrahedron 2006, 62 (41) , 9610-9621. https://doi.org/10.1016/j.tet.2006.07.075
    40. Nicholas J. Lawrence, E. Simon M. Armitage, Benjamin Greedy, Darren Cook, Sylvie Ducki, Alan T. McGown. The synthesis of indanones related to combretastatin A-4 via microwave-assisted Nazarov cyclization of chalcones. Tetrahedron Letters 2006, 47 (10) , 1637-1640. https://doi.org/10.1016/j.tetlet.2005.12.110
    41. Ming-Fu Cheng, Hui-Ming Yu, Bor-Wen Ko, Yu Chang, Ming-Yi Chen, Tong-Ing Ho, Yeun-Min Tsai, Jim-Min Fang. Practical synthesis of potential endothelin receptor antagonists of 1,4-benzodiazepine-2,5-dione derivatives bearing substituents at the C 3 -, N 1 - and N 4 -positions. Org. Biomol. Chem. 2006, 4 (3) , 510-518. https://doi.org/10.1039/B514937A
    42. Hélène Pellissier. Recent developments in the Nazarov process. Tetrahedron 2005, 61 (27) , 6479-6517. https://doi.org/10.1016/j.tet.2005.04.014
    43. Hirobumi Takahashi, Takehiro Fukami, Hisaki Kojima, Takeru Yamakawa, Hiroyuki Takahashi, Toshihiro Sakamoto, Teruyuki Nishimura, Masayuki Nakamura, Takashi Yosizumi, Kenji Niiyama, Norikazu Ohtake, Takashi Hayama. Convenient synthesis of 2-alkylamino-6-carboxy-5,7-diarylcyclopenteno[1,2-b]pyridines via direct acylamination with imidoyl chlorides. Tetrahedron 2005, 61 (14) , 3473-3481. https://doi.org/10.1016/j.tet.2005.02.003
    44. Takashi Yoshizumi, Hirobumi Takahashi, Norikazu Ohtake, Hideki Jona, Yoshiyuki Sato, Hiroyuki Kishino, Toshihiro Sakamoto, Satoshi Ozaki, Hiroyuki Takahashi, Yoshihiro Shibata, Yasuyuki Ishii, Michiyasu Saito, Megumu Okada, Takashi Hayama, Masaru Nishikibe. Potent and orally active ETA selective antagonists with 5,7-diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acid structures. Bioorganic & Medicinal Chemistry 2004, 12 (9) , 2139-2150. https://doi.org/10.1016/j.bmc.2004.02.033
    45. Hui‐Ming Yu, Min‐Jen Tseng, Jim‐Min Fang, Suree Phutrakul, Shui‐Tein Chen. Capillary electrophoresis using immobilized whole cells with overexpressed endothelin receptor for specific ligand screening. ELECTROPHORESIS 2004, 25 (7-8) , 1034-1041. https://doi.org/10.1002/elps.200305804
    46. Govindarajulu Babu, Hui-Ming Yu, Shyh-Ming Yang, Jim-Min Fang. Carbazolothiophene-2-carboxylic acid derivatives as endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2004, 14 (5) , 1129-1132. https://doi.org/10.1016/j.bmcl.2003.12.067
    47. Hirobumi Takahashi, Norikazu Ohtake, Toshihiro Sakamoto, Tomoharu Iino, Nobuhiko Kawanishi, Masayuki Nakamura, Takashi Yoshizumi, Kenji Niiyama, Satoshi Ozaki, Hiromasa Okada, Akiko Kano, Hiroyuki Takahashi, Yasuyuki Ishii, Megumu Okada, Michiyasu Saito, Yoshio Sawazaki, Takashi Hayama, Masaru Nishikibe. Structure–activity relationships of a novel class of endothelin receptor selective antagonists; 6-carboxy-2-isopropylamino-5,7-diarylcyclopenteno[1,2-b]pyridines. Bioorganic & Medicinal Chemistry Letters 2004, 14 (6) , 1503-1507. https://doi.org/10.1016/j.bmcl.2004.01.008
    48. Udo E.W Lange, Wilfried M Braje, Willi Amberg, Georg Kettschau. Solid-Phase synthesis of endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2003, 13 (10) , 1721-1724. https://doi.org/10.1016/S0960-894X(03)00236-1
    49. Zhu Li‐Li, Xu Xiao‐Jie. Three‐dimensional Quantitative Structure‐Activity Relationship Analyses of a Series of Butenolide ET A Antagonists. Chinese Journal of Chemistry 2003, 21 (3) , 261-269. https://doi.org/10.1002/cjoc.20030210310
    50. M. Angels Estiarte, Daniel H. Rich. Peptidomimetics for Drug Design. 2003, 633-685. https://doi.org/10.1002/0471266949.bmc014
    51. Daniel H. Rich, M. Angels Estiarte, A. Hart Philip. STEREOCHEMICAL ASPECTS OF DRUG ACTION I: CONFORMATIONAL RESTRICTION, STERIC HINDRANCE AND HYDROPHOBIC COLLAPSE. 2003, 373-386. https://doi.org/10.1016/B978-012744481-9/50027-1
    52. Kenji Niiyama, Hirobumi Takahashi, Toshio Nagase, Hisaki Kojima, Yuka Amano, Kasumi Katsuki, Takeru Yamakawa, Satoshi Ozaki, Masaki Ihara, Mitsuo Yano, Takahiro Fukuroda, Masaru Nishikibe, Kiyofumi Ishikawa. Structure–Activity relationships of 2-substituted 5,7-Diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acids as a novel class of endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2002, 12 (21) , 3041-3045. https://doi.org/10.1016/S0960-894X(02)00663-7
    53. Kenji Niiyama, Takashi Yoshizumi, Hirobumi Takahashi, Akira Naya, Norikazu Ohtake, Takehiro Fukami, Toshiaki Mase, Takashi Hayama, Kiyofumi Ishikawa. A Convenient Synthetic Method of a 5,7-Diarylcyclopenteno-[1,2-b]pyridine-6-carboxylate: A Key Intermediate for Potent Endothelin Receptor Antagonists. Bioorganic & Medicinal Chemistry 2002, 10 (11) , 3437-3444. https://doi.org/10.1016/S0968-0896(02)00261-4
    54. Kenji Niiyama, Toshiaki Mase, Hirobumi Takahashi, Akira Naya, Kasumi Katsuki, Toshio Nagase, Satoshi Ito, Takashi Hayama, Akihiro Hisaka, Satoshi Ozaki, Masaki Ihara, Mitsuo Yano, Takahiro Fukuroda, Kazuhito Noguchi, Masaru Nishikibe, Kiyofumi Ishikawa. 6-Carboxy-5,7-diarylcyclopenteno[1,2-b]pyridine derivatives. Bioorganic & Medicinal Chemistry 2002, 10 (8) , 2461-2470. https://doi.org/10.1016/S0968-0896(02)00122-0
    55. Jia-Ning Xiang, Steven T. Atkinson, Dimitri Gaitanopoulos, Deborah Bryan, Ponnal Nambi, Eliot H. Ohlstein, Joseph Weinstock, John D. Elliott. A novel series of ETA selective antagonists. 2002, 209-212. https://doi.org/10.1007/0-306-46859-X_73
    56. David J Rawson, Kevin N Dack, Roger P Dickinson, Kim James. The design and synthesis of a novel series of indole derived selective ETA antagonists. Bioorganic & Medicinal Chemistry Letters 2002, 12 (2) , 125-128. https://doi.org/10.1016/S0960-894X(01)00660-6
    57. Tong-Ing Ho, Wen-Shiong Chen, Chi-Wei Hsu, Yeun-Min Tsai, Jim-Min Fang. Synthesis of 1,4-Benzodiazepine- 2,5-dione Derivatives. HETEROCYCLES 2002, 57 (8) , 1501. https://doi.org/10.3987/COM-02-9525
    58. Hironori Harada, Jun-ichi Kazami, Susumu Watanuki, Ryuji Tsuzuki, Katsumi Sudoh, Akira Fujimori, Masanao Sanagi, Masaya Orita, Hideaki Nakahara, Jun Shimaya, Shin-ichi Tsukamoto, Akihiro Tanaka, Isao Yanagisawa. Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists. Bioorganic & Medicinal Chemistry 2001, 9 (11) , 2955-2968. https://doi.org/10.1016/S0968-0896(01)00187-0
    59. Paivi J. Kukkola, Natalie A. Bilci, Theodore Ikler, Paula Savage, Suraj S. Shetty, Dominick DelGrande, Arco Y. Jeng. Isoindolines: A new series of potent and selective endothelin-A receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2001, 11 (13) , 1737-1740. https://doi.org/10.1016/S0960-894X(01)00273-6
    60. O. Mansour, B. Szymonski, J. M. Morand, M. Cussac, F. Thomasson. Synthesis of 3‐Carboxylic derivatives of 1,5‐benzodiazepines. Journal of Heterocyclic Chemistry 2001, 38 (3) , 641-643. https://doi.org/10.1002/jhet.5570380315
    61. Yasuhiko Kanda, Yasuyuki Kawanishi, Katsuo Oda, Teruo Sakata, Shin-ichi Mihara, Kenji Asakura, Toshiyuki Kanemasa, Mitsuyoshi Ninomiya, Masafumi Fujimoto, Toshiro Konoike. Synthesis and structure–activity relationships of potent and orally active sulfonamide ETB selective antagonists. Bioorganic & Medicinal Chemistry 2001, 9 (4) , 897-907. https://doi.org/10.1016/S0968-0896(00)00305-9
    62. J. D. Elliott, J.-N. Xiang. Endothelin Receptor Antagonists. 2001, 239-270. https://doi.org/10.1007/978-3-642-56899-2_9
    63. Hironori HARADA, Jun-ichi KAZAMI, Susumu WATANUKI, Ryuji TSUZUKI, Katsumi SUDOH, Akira FUJIMORI, Tatsuhiro TOKUNAGA, Akihiro TANAKA, Shin-ichi TSUKAMOTO, Isao YANAGISAWA. Synthesis and Structure-Activity Relationships in a Series of Ethenesulfonamide Derivatives, a Novel Class of Endothelin Receptor Antagonists.. Chemical and Pharmaceutical Bulletin 2001, 49 (12) , 1593-1603. https://doi.org/10.1248/cpb.49.1593
    64. Hironori HARADA, Jun-ichi KAZAMI, Susumu WATANUKI, Ryuji TSUZUKI, Katsumi SUDOH, Akira FUJIMORI, Akihiro TANAKA, Shin-ichi TSUKAMOTO, Isao YANAGISAWA. Ethenesulfonamide Derivatives, a Novel Class of Orally Active Endothelin-A Receptor Antagonists. CHEMICAL & PHARMACEUTICAL BULLETIN 2001, 49 (5) , 606-612. https://doi.org/10.1248/cpb.49.606
    65. Jidong Zhang, Stanislas Didierlaurent, Michel Fortin, Dominique Lefrançois, Eric Uridat, Jean Paul Vevert. Potent nonpeptide endothelin antagonists. Bioorganic & Medicinal Chemistry Letters 2000, 10 (22) , 2575-2578. https://doi.org/10.1016/S0960-894X(00)00513-8
    66. Yasuhiko Kanda, Tadashi Takahashi, Yoshitaka Araki, Toshiro Konoike, Shin-ichi Mihara, Masafumi Fujimoto. Discovery and synthesis of a potent sulfonamide ETB selective antagonist. Bioorganic & Medicinal Chemistry Letters 2000, 10 (16) , 1875-1878. https://doi.org/10.1016/S0960-894X(00)00366-8
    67. Jean-Luc Haesslein, Isabelle Baholet, Michel Fortin, Alain Iltis, Jean Khider, Anne Marie Periers, Christine Pierre, Jean-Paul Vevert. 1,3-Disubstituted-2-carboxy quinolones: highly potent and selective endothelin A receptor antagonists. Bioorganic & Medicinal Chemistry Letters 2000, 10 (13) , 1487-1490. https://doi.org/10.1016/S0960-894X(00)00264-X
    68. Jidong Zhang, Stanislas Didierlaurent, Michel Fortin, Dominique Lefrançois, Eric Uridat, Jean Paul Vevert. Nonpeptide endothelin antagonists: from lower affinity pyrazol-5-ols to higher affinity pyrazole-5-carboxylic acids. Bioorganic & Medicinal Chemistry Letters 2000, 10 (12) , 1351-1355. https://doi.org/10.1016/S0960-894X(00)00232-8
    69. Michael Plotkin, Sanyou Chen, P.Grant Spoors. A practical approach to highly functionalized benzodihydrofurans. Tetrahedron Letters 2000, 41 (14) , 2269-2273. https://doi.org/10.1016/S0040-4039(00)00159-3
    70. Richard A. Lewis, Stephen D. Pickett, David E. Clark. Computer‐Aided Molecular Diversity Analysis and Combinatorial Library Design. 2000, 1-51. https://doi.org/10.1002/9780470125939.ch1
    71. Mitsuo Takahashi, Kuniya Sakurai, Seji Niwa, Seiji Oono. Pharmacophore Model of Endothelin Antagonists. 2000, 416-417. https://doi.org/10.1007/978-1-4615-4141-7_103
    72. Takashi Miyauchi, Yasuro Sugishita. Endothelin Antagonism in the Treatment of Heart Failure. 2000, 161-174. https://doi.org/10.1007/978-4-431-68331-5_15
    73. Steven A Boyd, Robert A Mantei, Andrew S Tasker, Gang Liu, Bryan K Sorensen, Kenneth J Henry Jr, Thomas W von Geldern, Martin Winn, Jinshyun R Wu-Wong, William J Chiou, Douglas B Dixon, Charles W Hutchins, Kennan C Marsh, Bach Nguyen, Terry J Opgenorth. Discovery of a series of pyrrolidine-based endothelin receptor antagonists with enhanced ETA receptor selectivity. Bioorganic & Medicinal Chemistry 1999, 7 (6) , 991-1002. https://doi.org/10.1016/S0968-0896(99)00022-X
    74. Takashi Miyauchi, Katsutoshi Goto. Heart failure and endothelin receptor antagonists. Trends in Pharmacological Sciences 1999, 20 (5) , 210-217. https://doi.org/10.1016/S0165-6147(99)01297-3
    75. Takashi Miyauchi, Tomoh Masaki. PATHOPHYSIOLOGY OF ENDOTHELIN IN THE CARDIOVASCULAR SYSTEM. Annual Review of Physiology 1999, 61 (1) , 391-415. https://doi.org/10.1146/annurev.physiol.61.1.391
    76. Ming Fai Chan, Adam Kois, Erik J. Verner, Bore G. Raju, Rosario S. Castillo, Chengde Wu, Ilya Okun, Fiona D. Stavros, V.N. Balaji. The discovery and structure—activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor. Bioorganic & Medicinal Chemistry 1998, 6 (12) , 2301-2316. https://doi.org/10.1016/S0968-0896(98)80010-2
    77. K.A. Berryman, J.J. Edmunds, A.M. Bunker, S. Haleen, J. Bryant, K.M. Welch, A.M. Doherty. Endothelin receptor antagonists: synthesis and structure–activity relationships of substituted benzothiazine-1,1-dioxides. Bioorganic & Medicinal Chemistry 1998, 6 (9) , 1447-1456. https://doi.org/10.1016/S0968-0896(98)00080-7
    78. Jia-Ning Xiang, Ponnal Nambi, Eliot H. Ohlstein, John D. Elliott. An Efficient Approach to the Synthesis of 1,3-Diaryl-1,2,3,4-[4H]-tetrahydronaphthalene-2-carboxylic Acids. Bioorganic & Medicinal Chemistry 1998, 6 (6) , 695-700. https://doi.org/10.1016/S0968-0896(98)00022-4
    79. Andrew S. Tasker, David M. Pollock. Endothelin Receptors and Receptor Antagonists. 1998, 3-15. https://doi.org/10.1007/978-3-662-11672-2_2
    80. Soheila Anzali, Werner W.K.R Mederski, Mathias Osswald, Dieter Dorsch. 1. Endothelin antagonists: Search for surrogates of methylendioxyphenyl by means of a kohonen neural network. Bioorganic & Medicinal Chemistry Letters 1998, 8 (1) , 11-16. https://doi.org/10.1016/S0960-894X(97)10150-0
    81. Werner W.K.R Mederski, Mathias Osswald, Dieter Dorsch, Soheila Anzali, Maria Christadler, Claus-Jochen Schmitges, Claudia Wilm. 2.Endothelin antagonists: Evaluation of 2,1,3-benzothiadiazole as a methylendioxyphenyl bioisoster. Bioorganic & Medicinal Chemistry Letters 1998, 8 (1) , 17-22. https://doi.org/10.1016/S0960-894X(97)10151-2
    82. Anthony P Davenport, Rhoda E Kuc, Michael J Ashby, William C Patt, Annette M Doherty. Characterization of [ 125 I]‐PD164333, an ET A selective non‐peptide radiolabelled antagonist, in normal and diseased human tissues. British Journal of Pharmacology 1998, 123 (2) , 223-230. https://doi.org/10.1038/sj.bjp.0701597
    83. B. Raju, Chengde Wu, Rosario Castillo, Ilya Okun, Fiona Stavros, Ming Fai Chan. 2-Aryloxycarbonylthiophene-3-sulfonamides: Highly potent and etA selective endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters 1997, 7 (16) , 2093-2098. https://doi.org/10.1016/S0960-894X(97)00367-3
    84. Werner W.K.R. Mederski, Mathias Osswald, Dieter Dorsch, Maria Christadler, Claus-Jochen Schmitges, Claudia Wilm. 1,4-Diaryl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acids as endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters 1997, 7 (14) , 1883-1886. https://doi.org/10.1016/S0960-894X(97)00319-3
    85. PC Astles, TJ Brown, CM Handscombe, MF Harper, NV Harris, RA Lewis, PM Lockey, C McCarthy, IM McLay, B Porter, AG Roach, C Smith, RJA Walsh. Selective endothelin A receptor ligands. 1. Discovery and structure-activity of 2,4-disubstituted benzoic acid derivatives. European Journal of Medicinal Chemistry 1997, 32 (5) , 409-423. https://doi.org/10.1016/S0223-5234(97)81678-9
    86. JS Kaltenbronn, J Quin, BR Reisdorph, S Klutchko, EE Reynolds, KM Welch, MA Flynn, AM Doherty. Benzofuran derivatives as ETA-selective, non-peptide endothelin antagonists. European Journal of Medicinal Chemistry 1997, 32 (5) , 425-431. https://doi.org/10.1016/S0223-5234(97)81679-0
    87. C. Flouzat, F. Marguerite, F. Croizet, M. Percebois, A. Monteil, M. Combourieu. Solid-phase synthesis of “head-to-side chain” cyclic tripeptides using allyl deprotection. Tetrahedron Letters 1997, 38 (7) , 1191-1194. https://doi.org/10.1016/S0040-4039(97)00061-0
    88. Maria L. Webb, Thomas D. Meek. Inhibitors of endothelin. Medicinal Research Reviews 1997, 17 (1) , 17-67. https://doi.org/10.1002/(SICI)1098-1128(199701)17:1<17::AID-MED2>3.0.CO;2-W
    89. Athanassios Giannis, Frank Rübsam. Peptidomimetics in Drug Design. 1997, 1-78. https://doi.org/10.1016/S0065-2490(97)80013-5
    90. Raymond McCague, Guy Casy. 5 Synthetic Methods for Enantiomers of Drugs. 1997, 203-261. https://doi.org/10.1016/S0079-6468(08)70108-5
    91. Harma Ellens, Evangeline P. Eddy, Chao-Pin Lee, Phyllis Dougherty, Amparo Lago, Jia-Ning Xiang, John D. Elliott, Hung-Yuan Cheng, Eliot Ohlstein, Philip L. Smith. In vitro permeability screening for identification of orally bioavailable endothelin receptor antagonists. Advanced Drug Delivery Reviews 1997, 23 (1-3) , 99-109. https://doi.org/10.1016/S0169-409X(96)00428-0
    92. X.-M. Cheng, C. Lee, S. Klutchko, T. Winters, E.E. Reynolds, K.M. Welch, M.A. Flynn, A.M. Doherty. Synthesis and structure-activity relationships of 9-substituted acridines as endothelin-A receptor antagonists. Bioorganic & Medicinal Chemistry Letters 1996, 6 (24) , 2999-3002. https://doi.org/10.1016/S0960-894X(96)00551-3
    93. Amy M. Bunker, Jeremy J. Edmunds, Kent A. Berryman, Donnelle M. Walker, Michael A. Flynn, Kathy M. Welch, Annette M. Doherty. 1-benzyl-3-thioaryl-2-carboxyindoles as potent non-peptide endothelin antagonists. Bioorganic & Medicinal Chemistry Letters 1996, 6 (12) , 1367-1370. https://doi.org/10.1016/0960-894X(96)00232-6
    94. Alois Fürstner, Andreas Ernst, Helga Krause, Arne Ptock. Low-valent titanium induced indole formation: Syntheses of secofascaplysin, indolopyridocoline and an endothelin-receptor-antagonist. Tetrahedron 1996, 52 (21) , 7329-7344. https://doi.org/10.1016/0040-4020(96)00255-4
    95. Amy M Bunker, Jeremy J Edmunds, Kent A Berryman, Donnelle M Walker, Michael A Flynn, Kathy M Welch, Annette M Doherty. 1,3-diaryl-2-carboxyindoles as potent non-peptide endothelin antagonists. Bioorganic & Medicinal Chemistry Letters 1996, 6 (9) , 1061-1066. https://doi.org/10.1016/0960-894X(96)00170-9
    96. Annette M. Doherty. Design and discovery of nonpeptide endothelin antagonists. Drug Discovery Today 1996, 1 (2) , 60-70. https://doi.org/10.1016/1359-6446(96)89090-8
    97. James R. Damewood. Peptide Mimetic Design with the Aid of Computational Chemistry. 1996, 1-80. https://doi.org/10.1002/9780470125861.ch1
    98. Katsutoshi Goto, Hiroshi Hama, Yoshitoshi Kasuya. Molecular Pharmacology and Pathophysiological Significance of Endothelin. Japanese Journal of Pharmacology 1996, 72 (4) , 261-290. https://doi.org/10.1254/jjp.72.261
    99. J. C. Hempel, R. M. Fine, M. Hassan, W. Ghoul, A. Guaragna, S. C. Koerber, Z. Li, A. T. Hagler. Conformational analysis of endothelin‐1: Effects of solvation free energy. Biopolymers 1995, 36 (3) , 283-301. https://doi.org/10.1002/bip.360360304
    100. Ritsuko Katahira, Kenji Shibata, Motoo Yamasaki, Yuzuru Matsuda, Mayumi Yoshida. Solution structure of endothelin B receptor selective antagonist RES-701-1 determined by 1H NMR spectroscopy. Bioorganic & Medicinal Chemistry 1995, 3 (9) , 1273-1280. https://doi.org/10.1016/0968-0896(95)00122-W
    Load all citations